The Th17/Treg imbalance in patients with acute coronary syndrome.
暂无分享,去创建一个
Yong Chen | Xiang Cheng | Y. Liao | Xian Yu | Ying-jun Ding | Q-Q Fu | J. Xie | T. Tang | Rui Yao | Jiang-jiao Xie | Qing-qing Fu
[1] Ohad Parnes,et al. Inflammation , 2008, The Lancet.
[2] O. Wiklund,et al. Dissociation of the Inflammatory Reaction following PCI for Acute Myocardial Infarction. , 2007, The Journal of invasive cardiology.
[3] C. Tato,et al. Distinct regulation of interleukin-17 in human T helper lymphocytes. , 2007, Arthritis and rheumatism.
[4] Kathleen M. Smith,et al. Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.
[5] P. Teeling,et al. Low Numbers of FOXP3 Positive Regulatory T Cells Are Present in all Developmental Stages of Human Atherosclerotic Lesions , 2007, PloS one.
[6] Hilde Cheroutre,et al. Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.
[7] Peng Liu,et al. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. , 2007, Clinical immunology.
[8] G. Keren,et al. Role of Naturally Occurring CD4+CD25+ Regulatory T Cells in Experimental Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[9] Satwat Hashmi,et al. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease , 2006, Coronary artery disease.
[10] G. Keren,et al. Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. , 2006, European heart journal.
[11] Da-zhu Li,et al. Generation of HSP60-specific regulatory T cell and effect on atherosclerosis. , 2006, Cellular immunology.
[12] [After TH1/TH2 now comes Treg/TH17: significance of T helper cells in immune response organization]. , 2006, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[13] Shimon Sakaguchi,et al. Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease , 2006, Immunological reviews.
[14] S. Nakae,et al. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[15] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[16] R. D. Hatton,et al. Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.
[17] R. Flavell,et al. Natural regulatory T cells control the development of atherosclerosis in mice , 2006, Nature Medicine.
[18] D. Littman,et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.
[19] R. Toes,et al. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. , 2005, Arthritis and rheumatism.
[20] E. Edelman,et al. Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. , 2005, Journal of the American College of Cardiology.
[21] T. Denning,et al. Cutting Edge: CD4+CD25+ Regulatory T Cells Impaired for Intestinal Homing Can Prevent Colitis12 , 2005, The Journal of Immunology.
[22] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[23] T. Geiger,et al. Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes. , 2005, Blood.
[24] Y. Liu,et al. Th1/Th2 Functional Imbalance After Acute Myocardial Infarction: Coronary Arterial Inflammation or Myocardial Inflammation , 2005, Journal of Clinical Immunology.
[25] A. Lindén,et al. Interleukin-17 family members and inflammation. , 2004, Immunity.
[26] D. Isenberg,et al. Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.
[27] Ehrenstein,et al. Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy , 2004 .
[28] Jeffrey A. Bluestone,et al. In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes , 2004, The Journal of experimental medicine.
[29] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[30] D. Ardissino,et al. Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction. , 2004, The American journal of cardiology.
[31] Z. Ungvari,et al. Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease. , 2004, Medical hypotheses.
[32] Li Li,et al. Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.
[33] S. Nakae,et al. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.
[34] J. Alcocer-Varela,et al. Quantification of regulatory T cells in patients with systemic lupus erythematosus. , 2003, Journal of autoimmunity.
[35] Z. Ungvari,et al. Aging‐induced proinflammatory shift in cytokine expression profile in rat coronary arteries , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] A. Andoh,et al. Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.
[37] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[38] Peter Libby,et al. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.
[39] M. Fishbein,et al. Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes , 2002, Circulation research.
[40] Svetlana Ten,et al. Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.
[41] G. Hansson,et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. , 2001, Circulation.
[42] U. Andersson,et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. , 1999, Atherosclerosis.
[43] T. Martin,et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.
[44] P. Kivisäkk,et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.
[45] K. Kugiyama,et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. , 1986, Circulation.